Bioprocessing & Biopartnering 2006 - Featuring NanoBiotechnology
Many people regard nanotechnology as a ‘standalone’
technology. While the technology itself
is of great interest, the most intriguing aspect
of nanotechnology is that it is increasingly
being utilised as an integral part of a more
complicated convergence matrix. The intersection
of nanotechnology, biotechnology, information
technology, and cognitive science, otherwise
referred to as ‘NBIC convergence’, is leading to
the development of nanobiotechnology products
that promise to change radically the provision of
healthcare in the decades ahead.
Nanotechnology refers broadly to the study and use of materials and structures at the nanoscale level of approximately 100 nanometres (nm) or less. The width of a nanometre is often compared to that of a human hair. One nanometre is 1/800th of a human hair, or 1/70th the diameter of a red blood cell.